UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

AIDS (London), 2006-06, Vol.20 (9), p.F9-F13

2006

Volltextzugriff (PDF)

Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1

Journal of Virology, 2009-02, Vol.83 (4), p.2029-2033

2009

Volltextzugriff (PDF)

Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV-1 Subtype C

The Journal of infectious diseases, 2009-10, Vol.200 (8), p.1202-1206

2009

Volltextzugriff (PDF)

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

Journal of Virology, 2002-02, Vol.76 (4), p.1753-1761

2002

Volltextzugriff (PDF)

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Clinical infectious diseases, 2019-08, Vol.69 (4), p.676-686

2019

Volltextzugriff (PDF)

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Clinical infectious diseases, 2022-01, Vol.74 (1), p.95-104

2022

Volltextzugriff (PDF)

HIV post-treatment controllers have distinct immunological and virological features

Proceedings of the National Academy of Sciences - PNAS, 2023-03, Vol.120 (11), p.e2218960120

2023

Volltextzugriff (PDF)

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

Clinical infectious diseases, 2023-07, Vol.77 (2), p.272-279

2023

Volltextzugriff (PDF)

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

The Journal of infectious diseases, 2007-04, Vol.195 (7), p.951-959

2007

Volltextzugriff (PDF)

Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance

Journal of antimicrobial chemotherapy, 2015-02, Vol.70 (2), p.405-411

2015

Volltextzugriff (PDF)

Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin interventionResearch in context

EBioMedicine, 2023-03, Vol.89, p.104468

2023

Volltextzugriff (PDF)

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

Journal of medical virology, 2011-05, Vol.83 (5), p.751-759

2011

Volltextzugriff (PDF)

Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec

The Journal of infectious diseases, 2011-10, Vol.204 (7), p.1115-1119

2011

Volltextzugriff (PDF)

A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy

Open forum infectious diseases, 2017-01, Vol.4 (1), p.ofw278-ofw278

2017

Volltextzugriff (PDF)

Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers

Open forum infectious diseases, 2023-02, Vol.10 (2), p.ofad063

2023

Volltextzugriff (PDF)

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2346-2349

2011

Volltextzugriff (PDF)

Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease

Open forum infectious diseases, 2023-08, Vol.10 (8), p.ofad328-ofad328

2023

Volltextzugriff (PDF)

Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239

Journal of virology, 2015-12, Vol.89 (23), p.12002-12013

2015

Volltextzugriff (PDF)

Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV

Cell reports. Medicine, 2024-10, Vol.5 (10), p.101745, Article 101745

2024

Volltextzugriff (PDF)

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

Open forum infectious diseases, 2021-06, Vol.8 (6), p.ofab245-ofab245

2021

Volltextzugriff (PDF)

Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects

Antiviral chemistry & chemotherapy, 2004-10, Vol.15 (5), p.255-259

2004

Volltextzugriff (PDF)

The preferential selection of K65R in HIV-1 subtype C is attenuated by nucleotide polymorphisms at thymidine analogue mutation sites

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2192-2196

2013

Volltextzugriff (PDF)

The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors

Journal of antimicrobial chemotherapy, 2012-04, Vol.67 (4), p.988-994

2012

Volltextzugriff (PDF)

HIV‐1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV‐1 group M

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19738-n/a

2014

Volltextzugriff (PDF)

In vitro and structural evaluation of PL-100 as a potential second-generation HIV-1 protease inhibitor

Journal of antimicrobial chemotherapy, 2013-01, Vol.68 (1), p.105-112

2013

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaAntiviral Agents

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)
Tagungsberichte
(2)

Sprache

Englisch
(35)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1

Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV-1 Subtype C

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

HIV post-treatment controllers have distinct immunological and virological features

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance

Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin interventionResearch in context

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec

A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy

Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease

Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239

Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects

The preferential selection of K65R in HIV-1 subtype C is attenuated by nucleotide polymorphisms at thymidine analogue mutation sites

The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors

HIV‐1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV‐1 group M

In vitro and structural evaluation of PL-100 as a potential second-generation HIV-1 protease inhibitor

Aktive Filter

Suchergebnisse filtern